Imazodan
Alternative Names: CI 914Latest Information Update: 02 Sep 2002
Price :
$50 *
At a glance
- Originator Pfizer
- Class Cardiotonics; Pyridazines; Small molecules; Vasodilators
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Heart failure; Ischaemic heart disorders
Most Recent Events
- 01 Feb 2002 Dicontinued for Heart failure
- 01 Feb 2002 Discontinued for Ischaemic heart disorders